NCM · Biotechnology

BioVie Inc. (BIVI) Stock

$1.39 +8.59% NCM: BIVI Healthcare

Valuation

MetricValue
Price$1.39
Market Cap$10.48M
P/E Ratio-0.46
P/B Ratio1.07
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$3.79
52-Week Low$0.82
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-126.02%
ROA-154.89%
ROCE-216.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.03
Current Ratio10.50

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-27.0M$-45.0M$-32.0M$-18.0M$-23.0M
Net Profit$-26.0M$-50.0M$-32.0M$-18.0M$-22.0M
EPS$-106.00$-154.70$-73.05$-12.12$-3.05
Op Margin—————

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$20.0M$35.0M$25.0M$22.0M$14.25T
Total Liabilities$16.0M$20.0M$10.0M$3.0M$3.98T
Cash$19.0M$19.0M$24.0M$18.0M$8.98T
Borrowings$12.0M$14.0M$6.0M$0$275.4B

Latest News

BioVie Files $300 Million Mixed Shelf MT Newswires · Jun 18, 2026 BioVie: Long COVID trial fully enrolled – ICYMI Proactive · May 29, 2026 Foremost Clean Energy and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ACCESS Newswire · May 29, 2026 Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 GlobeNewswire · May 27, 2026 BioVie completes enrollment in Long COVID trial as need for treatments grows Proactive · May 26, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-19.0M$-40.0M$-28.0M$-19.0M$-19.0B
Investing Cash Flow$0$-14.0M$15.0M$0$0
Financing Cash Flow$0$0$0$3.0M$0
Net Cash Flow$14.0M$1.0M$4.0M$-6.0M$-8.6B
Free Cash Flow$-19.0M$-40.0M$-28.0M$-19.0M$-19.0B

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.11
FCF Yield-172.77%
Quick Ratio3.59
Interest Coverage-1265.39
Return 1Y-74.68%
Return 3Y-99.65%
Return 5Y-99.88%

Ownership

Insiders Held0.36%
Institutions Held13.94%
Institutions Float Held13.98%
Institutional HolderSharesReport Date
Diametric Capital, Lp370,0002026-03-31
Prelude Capital Management LLC92,0632026-03-31
Geode Capital Management, LLC84,2032026-03-31
Vanguard Capital Management LLC84,0672026-03-31
Morgan Stanley75,2212026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARTLArtelo Biosciences, Inc. $3.26 -3.26% -0.05 $1.26M 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CEROCERo Therapeutics Holdings, Inc. $0.01 -7.69% 0.00 $14464 0.00%
ELABPMGC Holdings Inc. $3.08 -1.60% 0.00 $1.40M 0.00%
GLMD $4.63 +21.05% -0.28 $4.78M 0.00%

About BioVie Inc.

BioVie Inc. is led by CEO Cuong Viet Do, employs 14 people, headquartered in US, publicly traded since 2020.

BioVie Inc. (BIVI) stock trades at $1.39 with a market capitalization of $10.48M. The stock is valued at a price-to-earnings (P/E) ratio of -0.46, price-to-book of 1.07, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.82 and $3.79, and currently trades 63.3% below its 52-week high.

On profitability, BioVie Inc. generates a return on equity (ROE) of -126.02%, return on capital employed of -216.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides